BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9127689)

  • 21. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
    Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
    Wang XB; Yang QX; Pei XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2008; 49(2):181-8. PubMed ID: 18516324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cytospectrophotometric study of the DNA content in benign and malignant processes in the breast].
    Borodaĭ NV
    Tsitol Genet; 1999; 33(3):27-33. PubMed ID: 10474860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
    Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
    Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
    Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
    Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma within a fibroadenoma: a case report.
    Hemalatha AL; Raghupathi AR; Karthikeyan TM; Kumar DB; Shashidhar HB
    Indian J Pathol Microbiol; 2006 Oct; 49(4):592-4. PubMed ID: 17183868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
    Tökés AM; Hortoványi E; Csordás G; Kulka J; Mózes G; Hatalyák A; Kádár A
    Anticancer Res; 1999; 19(1A):175-9. PubMed ID: 10226540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.
    Okada K; Osaki M; Araki K; Ishiguro K; Ito H; Ohgi S
    Anticancer Res; 2005; 25(4):3003-9. PubMed ID: 16080559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
    Pilichowska M; Kimura N; Fujiwara H; Nagura H
    Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.
    Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K
    Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathepsin-D expression in breast lesion: an immunohistochemical study.
    Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
    Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive ductal carcinoma within a fibroadenoma of the breast.
    Abe H; Hanasawa K; Naitoh H; Endo Y; Tani T; Kushima R
    Int J Clin Oncol; 2004 Aug; 9(4):334-8. PubMed ID: 15375712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
    Gong Y; Sun X; Huo L; Wiley EL; Rao MS
    Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology of fibroadenoma of the breast.
    Kuijper A; Mommers EC; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2001 May; 115(5):736-42. PubMed ID: 11345838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in breast cancer is related to age but not to other prognostic parameters.
    Marinho A; Soares R; Ferro J; Lacerda M; Schmitt FC
    Pathol Res Pract; 1997; 193(4):267-73. PubMed ID: 9258952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.